Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125189003 | 12518900 | 3 | F | 20160626 | 20160831 | 20160630 | 20160907 | PER | US-CELGENEUS-USA-2016067043 | CELGENE | 58.18 | YR | M | Y | 64.90000 | KG | 20160906 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125189003 | 12518900 | 1 | PS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 21660 | 125 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 125189003 | 12518900 | 2 | SS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 21660 | 100 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 125189003 | 12518900 | 3 | SS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 21660 | 75 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 125189003 | 12518900 | 4 | SS | M402 (Necuparanib) | NECUPARANIB | 1 | Unknown | Y | U | 110454 | 0 | 5 | MG/KG | UNKNOWN | |||||
| 125189003 | 12518900 | 5 | SS | M402 (Necuparanib) | NECUPARANIB | 1 | Unknown | Y | U | 110454 | 0 | 5 | MG/KG | UNKNOWN | |||||
| 125189003 | 12518900 | 6 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | Y | U | 55974 | 1000 | MG/M**2 | UNKNOWN | ||||||
| 125189003 | 12518900 | 7 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | Y | U | 55974 | 800 | MG/M**2 | UNKNOWN | ||||||
| 125189003 | 12518900 | 8 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | Y | U | 55974 | 600 | MG/M**2 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125189003 | 12518900 | 1 | Pancreatic carcinoma metastatic |
| 125189003 | 12518900 | 4 | Pancreatic carcinoma metastatic |
| 125189003 | 12518900 | 6 | Pancreatic carcinoma metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125189003 | 12518900 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125189003 | 12518900 | Febrile neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125189003 | 12518900 | 1 | 20160527 | 0 | ||
| 125189003 | 12518900 | 2 | 20160613 | 20160621 | 0 | |
| 125189003 | 12518900 | 3 | 20160705 | 0 | ||
| 125189003 | 12518900 | 4 | 20160527 | 0 | ||
| 125189003 | 12518900 | 5 | 20160613 | 20160626 | 0 | |
| 125189003 | 12518900 | 6 | 20160527 | 0 | ||
| 125189003 | 12518900 | 7 | 20160613 | 20160621 | 0 | |
| 125189003 | 12518900 | 8 | 20160705 | 0 |